| SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | GT Biopharma, Inc. | 2,175,358 | 5.0% | EDGAR |
| SC 13G | 2023-09-19 | CYTOVANCE BIOLOGICS INC | GT Biopharma, Inc. | 2,755,817 | 6.8% | EDGAR |
| SC 13G | 2023-02-14 | ARMISTICE CAPITAL, LLC | GT Biopharma, Inc. | 3,676,186 | 10.0% | EDGAR |
| SC 13G/A | 2022-03-03 | BRISTOL INVESTMENT FUND LTD | GT Biopharma, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-01-28 | BIGGER CAPITAL FUND L P | GT Biopharma, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-01-18 | ALPHA CAPITAL ANSTALT | GT Biopharma, Inc. | 265,232 | 0.9% | EDGAR |
| SC 13G/A | 2021-04-16 | BRISTOL INVESTMENT FUND LTD | GT Biopharma, Inc. | 1,192,292 | 4.2% | EDGAR |
| SC 13G | 2021-02-17 | BIGGER CAPITAL FUND L P | GT Biopharma, Inc. | 729,029 | 3.5% | EDGAR |
| SC 13G/A | 2021-02-08 | BRISTOL INVESTMENT FUND LTD | GT Biopharma, Inc. | 6,619,779 | 7.9% | EDGAR |
| SC 13G/A | 2021-02-05 | ALPHA CAPITAL ANSTALT | GT Biopharma, Inc. | 6,021,400 | 7.2% | EDGAR |
| SC 13G | 2020-06-10 | BRISTOL INVESTMENT FUND LTD | GT Biopharma, Inc. | 6,619,779 | 9.4% | EDGAR |
| SC 13G/A | 2020-05-18 | BRISTOL INVESTMENT FUND LTD | GT Biopharma, Inc. | 3,594,133 | 5.1% | EDGAR |
| SC 13G/A | 2020-02-04 | BRISTOL INVESTMENT FUND LTD | GT Biopharma, Inc. | 3,016,846 | 4.5% | EDGAR |
| SC 13G/A | 2020-01-16 | ALPHA CAPITAL ANSTALT | GT Biopharma, Inc. | 6,736,475 | 10.0% | EDGAR |
| SC 13G/A | 2019-02-13 | ALPHA CAPITAL ANSTALT | GT Biopharma, Inc. | 2,966,667 | 5.9% | EDGAR |
| SC 13G/A | 2019-02-12 | BRISTOL INVESTMENT FUND LTD | GT Biopharma, Inc. | 4,534,795 | 9.0% | EDGAR |
| SC 13G/A | 2019-02-05 | Heavener James W | GT Biopharma, Inc. | 4,674,749 | 8.7% | EDGAR |
| SC 13G/A | 2019-01-29 | Heavener James W | GT Biopharma, Inc. | 2,182,321 | 4.3% | EDGAR |
| SC 13G/A | 2018-02-07 | BRISTOL INVESTMENT FUND LTD | GT Biopharma, Inc. | 4,819,789 | 9.6% | EDGAR |
| SC 13G | 2017-12-04 | Silverman Mark J | GT Biopharma, Inc. | 8,172,079 | 16.4% | EDGAR |